tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

Aivo A

New Portfolio
Individual Investor
Ranked #144,119 out of 820,848 TipRanks' Investors
Success Rate
62%
33 out of 53
profitable transactions
Average Return
42.40%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 18.69%
6-Month Return▲ 102.31%
12-Month Return▲ 91.02%
YTD Return▲ 75.73%
Total Return▲ 110.57%

Best Trade

Opened at
Closed at
Gain▲ 809.68%

Bio

Performance

22.84%0-22.84%
▼ 14.82%
▼ 1.27%
▼ 8.77%
Feb 2025
▼ 15.60%
▼ 5.57%
▼ 4.55%
Mar 2025
▼ 3.50%
▼ 0.87%
▲ 4.63%
Apr 2025
▲ 7.77%
▲ 6.28%
▲ 12.19%
May 2025
▲ 2.59%
▲ 5.14%
▲ 11.10%
Jun 2025
▲ 22.60%
▲ 2.30%
▲ 15.52%
Jul 2025
▼ 1.95%
▲ 2.05%
▲ 7.44%
Aug 2025
▲ 6.01%
▲ 3.56%
▲ 22.84%
Sep 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 14.82%▼ 1.27%▼ 8.77%
▼ 15.60%▼ 5.57%▼ 4.55%
▼ 3.50%▼ 0.87%▲ 4.63%
▲ 7.77%▲ 6.28%▲ 12.19%
▲ 2.59%▲ 5.14%▲ 11.10%
▲ 22.60%▲ 2.30%▲ 15.52%
▼ 1.95%▲ 2.05%▲ 7.44%
▲ 6.01%▲ 3.56%▲ 22.84%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Raytech Holding Limited
0.43%
▼ 52.86%
1
Open
Aug 27, 2025
Nvidia
2.62%
▲ 8.26%
3
Open
Aug 12, 2025
Altimmune
3.7%
▲ 56.18%
4
Buy
Jun 26, 2025
Aeva Technologies
▲ 158.02%
2
Close
May 12, 2025
Rheinmetall
16.33%
▲ 60.33%
1
Open
Apr 07, 2025
Xeris Pharmaceuticals
5.14%
▲ 127.93%
2
Buy
Mar 11, 2025
Chimerix
▲ 809.68%
2
Close
Mar 05, 2025
Rigetti Computing
8.36%
▲ 264.18%
1
Open
Mar 05, 2025
General Dynamics
▲ 23.36%
2
Close
Feb 04, 2025
Black Diamond Therapeutics
4.25%
▲ 53.44%
1
Open
Jan 28, 2025
Outset Medical
1.92%
▼ 14.42%
1
Open
Jan 07, 2025
Tenaya Therapeutics
2.27%
▼ 46.86%
2
Buy
Dec 13, 2024
Zura Bio
3.65%
▲ 60.37%
1
Open
Dec 03, 2024
Cleanspark
5.09%
▲ 29.20%
2
Buy
Sep 03, 2024
uniQure
▲ 38.63%
2
Close
Jul 10, 2024
Oatly Group
▼ 2.33%
2
Close
May 09, 2024
Olema Pharmaceuticals
1.72%
▼ 0.51%
1
Open
May 09, 2024
EOG Resources
▲ 18.38%
2
Close
Apr 09, 2024
Lineage Therap
2.63%
▲ 20.71%
1
Open
Apr 09, 2024
Genco Shipping
▲ 13.01%
4
Close
Mar 01, 2024